Lília Cristina de Souza Barbosa

Lília Cristina de Souza Barbosa

Auto-generated profile, based on publicly available information

Lília Cristina de Souza Barbosa

Instituto de Biociências, Universidade Federal de Jataí, Jataí, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2021 in Plant Cell, Tissue and Organ Culture (PCTOC)
Verified
Journal Article
Closed access
PDF file
AMAndréia Izabel Mikovski
Andréia Izabel Mikovski
NSNayara Tayane da Silva
Nayara Tayane da Silva
LSLázara Aline Simões Silva
Lázara Aline Simões Silva
MMMariana Machado
Mariana Machado
LBLília Cristina de Souza Barbosa
Lília Cristina de Souza Barbosa
MSMaurecilne Lemes da Silva
Maurecilne Lemes da Silva


1 July 2022 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
KBKellen Christina Malheiros Borges
Kellen Christina Malheiros Borges
ACAdeliane Castro da Costa
Adeliane Castro da Costa
LBLília Cristina de Souza Barbosa
Lília Cristina de Souza Barbosa
KRKaio Mota Ribeiro
Kaio Mota Ribeiro
LALaura Raniere Borges dos Anjos
Laura Raniere Borges dos Anjos
Ana Paula Junqueira-KipnisAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis
Evidence from multiple scientific studies suggests that the Bacillus Calmette–Guérin (BCG) vaccine, widely used worldwide as a preventive measure against tuberculosis, also offers crossprotection against other pathogens. This review aimed to gather data from research that studied the mechanisms involved in the immunological protection induced by the BCG vaccine, which may be important in the control of viral infections, such as COVID-19. Through a literature review, we compiled information about the different BCG strains used worldwide, as well as the responses and protection elicited by them. We commented on the mechanisms of immune response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and we discussed the possibility of cross-protection of different BCG strains on the control of COVID-19. Due to the immunomodulatory properties of BCG, some BCG strains were able to induce an effective cellular immune response and, through epigenetic modifications, activate cells of the innate immune system, such as monocytes, macrophages and natural killer cells, which are crucial for the control of viral infections. Although several vaccines have already been developed and used in an attempt to control the COVID-19 pandemic, some BCG vaccine strains may help stimulate the basal defences against these pathogens and can be used as additional defences in this and future pandemics.



1 October 2018 in Acta Horticulturae
Verified
Journal Article
Closed access
EAE.V.E.J. Amaral
E.V.E.J. Amaral
JSJ.F. Sales
J.F. Sales
JPJ.F.N. Pinto
J.F.N. Pinto
LBL.C.S. Barbosa
L.C.S. Barbosa
ERE.F. Reis
E.F. Reis
SFSebastião Carvalho Vasconcelos Filho
Sebastião Carvalho Vasconcelos Filho